|1.||Ardia, Alfredo: 4 articles (06/2003 - 07/2002)|
|2.||Pallotta, Teresa: 3 articles (06/2003 - 07/2002)|
|3.||Cattaneo, Dario: 2 articles (11/2010 - 10/2009)|
|4.||Clementi, Emilio: 2 articles (11/2010 - 10/2009)|
|5.||Mehlisch, Donald R: 2 articles (06/2003 - 08/2002)|
|6.||Black, Peter: 2 articles (09/2002 - 07/2002)|
|7.||Desjardins, Paul: 2 articles (09/2002 - 07/2002)|
|8.||Ortega-Álvaro, Antonio: 1 article (01/2012)|
|9.||Rey-Brea, Raquel: 1 article (01/2012)|
|10.||Berrocoso, Esther: 1 article (01/2012)|
07/01/2002 - "Significantly greater numbers of patients achieved meaningful pain relief with ibuprofen arginate 400 mg compared with placebo from 20 minutes through 6 hours and with ibuprofen arginate 200 mg from 30 minutes through 6 hours (P < 0.05). "
12/01/2009 - "This study evaluated the effectiveness of 400 mg ibuprofen arginate either as a pre-emptive (PRE group) or postoperative (POST group) analgesic using a common dental pain model. "
01/01/2004 - "In this open trial, patients received an initial oral dose of ibuprofen arginine 600mg at the onset of pain, followed by the same dose every 6 hours, if necessary, with a maximum daily dose of 2400mg. "
11/01/2010 - "Taken together, the pharmacokinetic/dynamic characteristics of ibuprofen arginine can be considered particularly favorable for several clinical conditions, such as moderate/severe pain, in which a rapid pharmacologic effect is required."
07/01/2010 - "Placebo and ibuprofen-arginine administration induced activation bilaterally in the premotor cortex, and an overall reduction in the other pain-related areas, which was more prominent in the left hemisphere. "
|2.||Low Back Pain (Lumbago)
12/01/2006 - "An early lowering of the serum NO metabolite levels after ibuprofen-arginine administration could be detected in patients with chronic low back pain."
12/01/2006 - "Patients with chronic low back pain were randomly divided into 2 groups treated either with oral ibuprofen-arginine (400 mg) or with placebo. "
12/01/2006 - "Influence of ibuprofen-arginine on serum levels of nitric oxide metabolites in patients with chronic low back pain--a single-blind, placebo controlled pilot trial (ISRCTN18723747)."
|3.||Migraine Disorders (Migraine)
|4.||Dysmenorrhea (Menstrual Pain)
06/01/2003 - "Analgesia with ibuprofen arginate versus conventional ibuprofen for patients with dysmenorrhea: a crossover trial."
06/01/2003 - "The aim of this study was to compare the analgesic efficacy, including onset and duration of pain relief, peak effect, and total effect, and tolerability of ibuprofen arginate with those of conventional ibuprofen in patients with moderate to severe pain associated with primary dysmenorrhea. "
06/01/2003 - "In this study population of patients experiencing acute pain as a result of primary dysmenorrhea, ibuprofen arginate was associated with effective, tolerable analgesia and a more rapid onset of action than conventional ibuprofen. "
05/01/2006 - "64 patients with chronic periodontitis received either 800 mg ibuprofen arginine or placebo 30 min. before treatment. "
05/01/2006 - "In patients with mild-to-moderate chronic periodontitis, ibuprofen arginine was safe and superior to placebo for alleviating pain during non-surgical periodontal treatment. "
|3.||Nitric Oxide (Nitrogen Monoxide)
|4.||Morphine (MS Contin)
|5.||Analgesics (Analgesic Drugs)
|6.||Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)